213
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation

, ORCID Icon, , , ORCID Icon, , , ORCID Icon, , & show all
Pages 485-494 | Received 13 Mar 2023, Accepted 11 Jun 2023, Published online: 17 Jul 2023

References

  • Gritsch S, Batchelor TT, Gonzalez Castro LN. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer. 2022;128(1):47–58.
  • Kaptein AA, Schoones JW, Fischer MJ, Thong MS, Kroep JR, van der Hoeven KJ. Illness perceptions in women with breast cancer-a systematic literature review. Curr Breast Cancer Rep. 2015;7(3):117–126.
  • Fanakidou I, Zyga S, Alikari V, Tsironi M, Stathoulis J, Theofilou P. Mental health, loneliness, and illness perception outcomes in quality of life among young breast cancer patients after mastectomy: the role of breast reconstruction. Qual Life Res. 2018;27(2):539–543.
  • Zdenkowski N, Tesson S, Lombard J, et al. Supportive care of women with breast cancer: key concerns and practical solutions. Med J Aust. 2016;205(10):471–475.
  • Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology. 2008;17(4):317–328.
  • Abu-Helalah M, Al-Hanaqta M, Alshraideh H, Abdulbaqi N, Hijazeen J. Quality of life and psychological well-being of breast cancer survivors in Jordan. Asian Pac J Cancer Prev. 2014;15(14):5927–5936.
  • Helms RL, O’Hea EL, Corso M. Body image issues in women with breast cancer. Psychol Health Med. 2008;13(3):313–325.
  • Batchelor D. Hair and cancer chemotherapy: consequences and nursing care--a literature study. Eur J Cancer Care (Engl). 2001;10(3):147–163.
  • Bajpai J, Kagwade S, Chandrasekharan A, et al. ”Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia”. Breast. 2020;49:187–193.
  • Munzone E, Bagnardi V, Campennì G, et al. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. Br J Cancer. 2019;121(4):325–331.
  • Rugo HS, Klein P, Melin SA, et al. Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA. 2017;317(6):606–614.
  • Smetanay K, Junio P, Feißt M, et al. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat. 2019;173(1):135–143.
  • de Barros Silva G, Donati A, van den Hurk CJ. Comments regarding “Hair regrowth during chemotherapy after scalp cooling technique”. Int J Dermatol. 2017;56(3):e57–e59.
  • Marks DH, Okhovat JP, Hagigeorges D, et al. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Res Treat. 2019;175(2):267–276.
  • Brunner C, Emmelheinz M, Kofler R, et al. Hair safe study: effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study. Breast. 2022;64:50–55.
  • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
  • Michels FA, Latorre Mdo R, Maciel Mdo S. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer. Br j epidemiol. 2013;16(2):352–363.
  • Hopwood P, Fletcher I, Lee A, Al Ghazal S. A body image scale for use with cancer patients. Eur J Cancer. 2001;37(2):189–197.
  • Chan A, Bauwens A, Pontre S, et al. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. Breast. 2018;41:127–132.
  • Wang S, Yang T, Shen A, Qiang W, Zhao Z, Zhang F. The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Support Care Cancer. 2021;29(11):6943–6956.
  • Komen MM, Smorenburg CH, van den Hurk CJ, Nortier JW. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist. 2013;18(7):885–891.
  • Fraser J, Steele N, Al Zaman A, Yule A. Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group. Eur J Cancer. 2011;47(2):215–220.
  • Blanco C, Olfson M, Goodwin RD, et al. Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(8):1276–1280.
  • He Z, Tang X, Yang X, et al. Clinical trial generalizability assessment in the big data era: a review. Clin Transl Sci. 2020;13(4):675–684.
  • Jung-Woo Chae RN. Alexandre Chan Chemotherapy drug concentrations in hair follicles: a potential biomarker to monitor the effectiveness of scalp cooling for chemotherapy-induced alopecia. Support Care Cancer. 2018;26(11):3669–3670.